Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Skin Neoplasms | 29 | 2025 | 5863 | 3.880 |
Why?
|
Carcinoma, Squamous Cell | 14 | 2025 | 4058 | 2.430 |
Why?
|
Th2 Cells | 4 | 2025 | 1078 | 1.780 |
Why?
|
Skin | 13 | 2024 | 4503 | 1.600 |
Why?
|
Cytokines | 16 | 2025 | 7453 | 1.600 |
Why?
|
Calcitriol | 6 | 2025 | 303 | 1.410 |
Why?
|
Interleukins | 2 | 2025 | 796 | 1.340 |
Why?
|
Scleroderma, Systemic | 2 | 2023 | 346 | 1.230 |
Why?
|
Fluorouracil | 6 | 2025 | 1652 | 1.080 |
Why?
|
Receptors, Notch | 6 | 2020 | 751 | 1.080 |
Why?
|
Dermatitis, Allergic Contact | 2 | 2019 | 112 | 0.980 |
Why?
|
Carcinogens | 3 | 2023 | 453 | 0.970 |
Why?
|
Precancerous Conditions | 3 | 2025 | 985 | 0.970 |
Why?
|
Cancer Vaccines | 2 | 2022 | 1041 | 0.920 |
Why?
|
Epidermis | 4 | 2019 | 539 | 0.870 |
Why?
|
HMGB1 Protein | 1 | 2025 | 141 | 0.860 |
Why?
|
5'-Nucleotidase | 1 | 2024 | 164 | 0.840 |
Why?
|
Colitis | 2 | 2023 | 1242 | 0.820 |
Why?
|
Tumor Microenvironment | 3 | 2024 | 3948 | 0.810 |
Why?
|
Papillomaviridae | 4 | 2024 | 1140 | 0.790 |
Why?
|
Keratinocytes | 9 | 2025 | 876 | 0.790 |
Why?
|
Smad6 Protein | 1 | 2021 | 14 | 0.750 |
Why?
|
T-Lymphocytes, Regulatory | 5 | 2023 | 3114 | 0.740 |
Why?
|
Alphapapillomavirus | 2 | 2020 | 219 | 0.730 |
Why?
|
Killer Cells, Natural | 4 | 2023 | 2211 | 0.720 |
Why?
|
Immunotherapy | 9 | 2025 | 4755 | 0.700 |
Why?
|
Papillomavirus Infections | 2 | 2024 | 1640 | 0.700 |
Why?
|
Melanoma, Experimental | 1 | 2023 | 559 | 0.660 |
Why?
|
Lichen Planus | 1 | 2020 | 70 | 0.650 |
Why?
|
Langerhans Cells | 1 | 2019 | 169 | 0.640 |
Why?
|
Skin Physiological Phenomena | 1 | 2020 | 193 | 0.640 |
Why?
|
Mice | 35 | 2025 | 82029 | 0.600 |
Why?
|
Laser Therapy | 2 | 2024 | 1107 | 0.600 |
Why?
|
Chemokines, CXC | 1 | 2019 | 420 | 0.600 |
Why?
|
Lupus Erythematosus, Discoid | 1 | 2018 | 61 | 0.590 |
Why?
|
Extracellular Matrix Proteins | 1 | 2022 | 832 | 0.580 |
Why?
|
Extracellular Matrix | 2 | 2022 | 1738 | 0.580 |
Why?
|
Symbiosis | 1 | 2019 | 297 | 0.560 |
Why?
|
Cytomegalovirus Infections | 1 | 2023 | 837 | 0.530 |
Why?
|
Virus Diseases | 1 | 2022 | 724 | 0.530 |
Why?
|
Protein Processing, Post-Translational | 1 | 2024 | 1966 | 0.520 |
Why?
|
Immunity, Cellular | 3 | 2017 | 1561 | 0.520 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2023 | 952 | 0.510 |
Why?
|
Keratosis, Actinic | 1 | 2016 | 71 | 0.510 |
Why?
|
Homeostasis | 2 | 2024 | 3348 | 0.470 |
Why?
|
Animals | 38 | 2025 | 169246 | 0.470 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2024 | 2954 | 0.460 |
Why?
|
Skin Diseases | 1 | 2023 | 1085 | 0.460 |
Why?
|
Tumor Suppressor Proteins | 2 | 2016 | 2810 | 0.450 |
Why?
|
Lung Neoplasms | 3 | 2023 | 13586 | 0.440 |
Why?
|
CD8-Positive T-Lymphocytes | 5 | 2024 | 4648 | 0.440 |
Why?
|
CD4-Positive T-Lymphocytes | 6 | 2023 | 4415 | 0.430 |
Why?
|
Carcinoma, Basal Cell | 3 | 2024 | 565 | 0.430 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2016 | 506 | 0.420 |
Why?
|
Organ Transplantation | 2 | 2022 | 1176 | 0.420 |
Why?
|
Signal Transduction | 11 | 2024 | 23645 | 0.390 |
Why?
|
Melanoma | 4 | 2023 | 5706 | 0.380 |
Why?
|
Adaptive Immunity | 4 | 2024 | 733 | 0.380 |
Why?
|
HLA Antigens | 3 | 2023 | 1334 | 0.370 |
Why?
|
Sarcoma | 1 | 2022 | 1806 | 0.370 |
Why?
|
Breast Neoplasms | 3 | 2025 | 21206 | 0.370 |
Why?
|
Health Promotion | 1 | 2022 | 2210 | 0.350 |
Why?
|
Monocytes | 1 | 2019 | 2605 | 0.340 |
Why?
|
Immunoglobulin J Recombination Signal Sequence-Binding Protein | 4 | 2020 | 133 | 0.340 |
Why?
|
Receptor, Notch1 | 3 | 2010 | 519 | 0.340 |
Why?
|
Macrophages | 1 | 2025 | 5799 | 0.330 |
Why?
|
Hair Follicle | 2 | 2009 | 219 | 0.330 |
Why?
|
Ultraviolet Rays | 3 | 2024 | 1103 | 0.320 |
Why?
|
Humans | 56 | 2025 | 768166 | 0.310 |
Why?
|
Inflammation | 5 | 2024 | 10873 | 0.290 |
Why?
|
Pancreatic Neoplasms | 2 | 2024 | 5446 | 0.280 |
Why?
|
Leukemia, Mast-Cell | 1 | 2006 | 13 | 0.270 |
Why?
|
Neoplasms | 8 | 2024 | 22371 | 0.260 |
Why?
|
Mice, Inbred C57BL | 7 | 2024 | 22379 | 0.260 |
Why?
|
Cell Line, Tumor | 8 | 2025 | 17140 | 0.250 |
Why?
|
Immunocompromised Host | 2 | 2022 | 863 | 0.250 |
Why?
|
Betapapillomavirus | 1 | 2024 | 15 | 0.240 |
Why?
|
Fibrosis | 2 | 2023 | 2080 | 0.240 |
Why?
|
Dermatitis, Atopic | 2 | 2010 | 737 | 0.240 |
Why?
|
Genes, Tumor Suppressor | 1 | 2009 | 1062 | 0.240 |
Why?
|
Stromal Cells | 2 | 2009 | 1336 | 0.230 |
Why?
|
Lymphoproliferative Disorders | 1 | 2008 | 528 | 0.230 |
Why?
|
Toll-Like Receptor 4 | 2 | 2025 | 588 | 0.230 |
Why?
|
Electrocoagulation | 1 | 2024 | 156 | 0.230 |
Why?
|
Cryotherapy | 1 | 2024 | 164 | 0.220 |
Why?
|
Mastocytosis | 1 | 2006 | 150 | 0.220 |
Why?
|
Collagen | 2 | 2022 | 2643 | 0.220 |
Why?
|
Xeroderma Pigmentosum | 1 | 2023 | 31 | 0.210 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2023 | 11878 | 0.210 |
Why?
|
Mice, Knockout | 10 | 2024 | 14488 | 0.210 |
Why?
|
Interferon Regulatory Factor-3 | 1 | 2024 | 146 | 0.210 |
Why?
|
Colorectal Neoplasms | 2 | 2023 | 6974 | 0.210 |
Why?
|
Female | 26 | 2025 | 397192 | 0.200 |
Why?
|
Bleomycin | 1 | 2022 | 492 | 0.180 |
Why?
|
Immunity, Innate | 2 | 2024 | 3080 | 0.180 |
Why?
|
Antigens, Neoplasm | 2 | 2019 | 1997 | 0.180 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2021 | 157 | 0.170 |
Why?
|
Dendritic Cells | 2 | 2023 | 2747 | 0.170 |
Why?
|
Cell Differentiation | 5 | 2023 | 11669 | 0.170 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13676 | 0.170 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2024 | 329 | 0.170 |
Why?
|
Allergy and Immunology | 1 | 2021 | 175 | 0.170 |
Why?
|
Nevus, Pigmented | 1 | 2022 | 222 | 0.170 |
Why?
|
Cell Lineage | 1 | 2009 | 2575 | 0.170 |
Why?
|
Interleukin-13 | 1 | 2022 | 390 | 0.170 |
Why?
|
Receptors, CCR6 | 1 | 2019 | 73 | 0.170 |
Why?
|
Mannose-Binding Lectins | 1 | 2019 | 101 | 0.160 |
Why?
|
Arginine | 1 | 2023 | 932 | 0.160 |
Why?
|
Chronic Disease | 4 | 2019 | 9384 | 0.160 |
Why?
|
Paget Disease, Extramammary | 1 | 2019 | 50 | 0.160 |
Why?
|
Quinolines | 1 | 2024 | 772 | 0.150 |
Why?
|
Cytomegalovirus | 1 | 2023 | 753 | 0.150 |
Why?
|
Administration, Topical | 2 | 2019 | 703 | 0.150 |
Why?
|
Mice, Inbred MRL lpr | 1 | 2018 | 158 | 0.150 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2022 | 1353 | 0.150 |
Why?
|
Exanthema | 1 | 2023 | 503 | 0.150 |
Why?
|
Lasers | 2 | 2024 | 952 | 0.150 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2020 | 392 | 0.150 |
Why?
|
STAT3 Transcription Factor | 1 | 2022 | 874 | 0.140 |
Why?
|
Forkhead Transcription Factors | 2 | 2022 | 1625 | 0.140 |
Why?
|
DNA Virus Infections | 1 | 2017 | 15 | 0.140 |
Why?
|
Genes, MHC Class II | 1 | 2018 | 433 | 0.140 |
Why?
|
Th1 Cells | 1 | 2022 | 1042 | 0.140 |
Why?
|
Cell Count | 2 | 2019 | 1832 | 0.140 |
Why?
|
Antibodies, Bispecific | 1 | 2019 | 204 | 0.130 |
Why?
|
Disease Models, Animal | 4 | 2022 | 18349 | 0.130 |
Why?
|
Lectins, C-Type | 1 | 2019 | 594 | 0.130 |
Why?
|
Lasers, Gas | 1 | 2017 | 104 | 0.130 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2023 | 1801 | 0.130 |
Why?
|
Stem Cells | 1 | 2009 | 3537 | 0.130 |
Why?
|
Ligands | 1 | 2022 | 3284 | 0.120 |
Why?
|
B-Lymphocytes | 2 | 2008 | 4793 | 0.120 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2022 | 1361 | 0.120 |
Why?
|
Epithelium | 1 | 2020 | 1607 | 0.120 |
Why?
|
Neutrophil Infiltration | 1 | 2017 | 393 | 0.120 |
Why?
|
Immunity | 2 | 2017 | 1003 | 0.120 |
Why?
|
Neoplasm Proteins | 2 | 2024 | 3603 | 0.120 |
Why?
|
Physicians | 2 | 2023 | 4598 | 0.120 |
Why?
|
Nickel | 1 | 2014 | 126 | 0.110 |
Why?
|
Oncogenes | 1 | 2019 | 1234 | 0.110 |
Why?
|
Disease Progression | 2 | 2020 | 13671 | 0.110 |
Why?
|
Internal Fixators | 1 | 2014 | 183 | 0.110 |
Why?
|
Fibroblasts | 2 | 2023 | 4176 | 0.110 |
Why?
|
Lymphocytes | 1 | 2021 | 2614 | 0.110 |
Why?
|
Transforming Growth Factor beta | 1 | 2021 | 1996 | 0.100 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2021 | 2846 | 0.100 |
Why?
|
Aged | 9 | 2024 | 171504 | 0.100 |
Why?
|
Microscopy, Fluorescence | 1 | 2019 | 2633 | 0.100 |
Why?
|
Cell Nucleus | 1 | 2021 | 2885 | 0.100 |
Why?
|
Psoriasis | 1 | 2020 | 926 | 0.100 |
Why?
|
Middle Aged | 10 | 2024 | 223492 | 0.100 |
Why?
|
Neoplasm Metastasis | 1 | 2022 | 4912 | 0.090 |
Why?
|
RNA, Viral | 1 | 2019 | 2872 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-kit | 2 | 2005 | 725 | 0.090 |
Why?
|
Dermatitis | 1 | 2012 | 203 | 0.090 |
Why?
|
Pruritus | 1 | 2013 | 379 | 0.090 |
Why?
|
Asthma | 1 | 2009 | 6291 | 0.090 |
Why?
|
Desmogleins | 1 | 2009 | 4 | 0.090 |
Why?
|
Genes, ras | 1 | 2012 | 663 | 0.080 |
Why?
|
Dermatology | 1 | 2020 | 905 | 0.080 |
Why?
|
9,10-Dimethyl-1,2-benzanthracene | 1 | 2009 | 58 | 0.080 |
Why?
|
Up-Regulation | 1 | 2019 | 4146 | 0.080 |
Why?
|
Cell Line | 2 | 2021 | 15597 | 0.080 |
Why?
|
Aged, 80 and over | 4 | 2019 | 59629 | 0.080 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2023 | 2059 | 0.080 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 3251 | 0.080 |
Why?
|
Antigens, CD | 1 | 2019 | 4035 | 0.080 |
Why?
|
Lung | 2 | 2023 | 10099 | 0.080 |
Why?
|
Epithelial Cells | 1 | 2021 | 3703 | 0.080 |
Why?
|
Sensory Receptor Cells | 1 | 2013 | 508 | 0.080 |
Why?
|
Mice, Transgenic | 3 | 2016 | 9561 | 0.080 |
Why?
|
T-Lymphocytes | 2 | 2023 | 10266 | 0.080 |
Why?
|
Medical Oncology | 1 | 2020 | 2346 | 0.080 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2009 | 826 | 0.080 |
Why?
|
Cell Movement | 1 | 2019 | 5210 | 0.070 |
Why?
|
Keratins | 1 | 2009 | 499 | 0.070 |
Why?
|
Osteopontin | 1 | 2009 | 306 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3833 | 0.070 |
Why?
|
Mutation | 4 | 2024 | 30238 | 0.070 |
Why?
|
Male | 12 | 2024 | 364719 | 0.070 |
Why?
|
Biomedical Research | 1 | 2021 | 3463 | 0.060 |
Why?
|
Hair | 1 | 2009 | 508 | 0.060 |
Why?
|
Colonic Neoplasms | 1 | 2017 | 2541 | 0.060 |
Why?
|
Mice, Inbred DBA | 1 | 2006 | 624 | 0.060 |
Why?
|
Double-Blind Method | 1 | 2019 | 12465 | 0.060 |
Why?
|
Neutrophils | 1 | 2017 | 3786 | 0.060 |
Why?
|
Mevalonic Acid | 1 | 2024 | 46 | 0.060 |
Why?
|
Glioblastoma | 1 | 2019 | 3464 | 0.060 |
Why?
|
Leukocyte Count | 1 | 2008 | 1609 | 0.060 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2008 | 616 | 0.060 |
Why?
|
Palliative Care | 1 | 2019 | 3643 | 0.060 |
Why?
|
Hypersensitivity | 1 | 2013 | 1172 | 0.060 |
Why?
|
Toll-Like Receptor 3 | 1 | 2024 | 99 | 0.060 |
Why?
|
Apoptosis | 1 | 2019 | 9523 | 0.050 |
Why?
|
Myeloproliferative Disorders | 1 | 2010 | 616 | 0.050 |
Why?
|
Survival Analysis | 3 | 2017 | 10101 | 0.050 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2005 | 430 | 0.050 |
Why?
|
Age Factors | 1 | 2019 | 18412 | 0.050 |
Why?
|
Animals, Newborn | 1 | 2008 | 2678 | 0.050 |
Why?
|
Protein-Arginine N-Methyltransferases | 1 | 2023 | 129 | 0.050 |
Why?
|
Cell Proliferation | 2 | 2008 | 10474 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5367 | 0.050 |
Why?
|
Gene Deletion | 1 | 2009 | 2675 | 0.050 |
Why?
|
Pancreatitis, Chronic | 1 | 2024 | 282 | 0.050 |
Why?
|
Mice, Inbred BALB C | 3 | 2017 | 6231 | 0.050 |
Why?
|
Drug Eruptions | 1 | 2024 | 335 | 0.050 |
Why?
|
Immunophenotyping | 1 | 2006 | 1864 | 0.050 |
Why?
|
Longevity | 1 | 2008 | 1077 | 0.040 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2005 | 686 | 0.040 |
Why?
|
Pyrimidinones | 1 | 2023 | 386 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 637 | 0.040 |
Why?
|
Cell Communication | 1 | 2007 | 1660 | 0.040 |
Why?
|
Homeodomain Proteins | 1 | 2009 | 2429 | 0.040 |
Why?
|
Flow Cytometry | 2 | 2010 | 5902 | 0.040 |
Why?
|
Research Personnel | 1 | 2023 | 589 | 0.040 |
Why?
|
Azacitidine | 1 | 2020 | 336 | 0.040 |
Why?
|
Adenosine Triphosphate | 1 | 2005 | 2004 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2018 | 16045 | 0.040 |
Why?
|
Blotting, Western | 1 | 2006 | 5027 | 0.040 |
Why?
|
Neoplasm Transplantation | 1 | 2022 | 2014 | 0.040 |
Why?
|
Mentors | 1 | 2023 | 671 | 0.040 |
Why?
|
Photolysis | 1 | 2017 | 94 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2013 | 11928 | 0.040 |
Why?
|
Piperazines | 2 | 2005 | 2554 | 0.040 |
Why?
|
Granzymes | 1 | 2019 | 277 | 0.040 |
Why?
|
Pyridones | 1 | 2023 | 819 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 2 | 2023 | 5703 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2004 | 1627 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2017 | 794 | 0.030 |
Why?
|
Gene Frequency | 2 | 2017 | 3623 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2019 | 1837 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2005 | 3728 | 0.030 |
Why?
|
Prospective Studies | 1 | 2019 | 54926 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2019 | 1230 | 0.030 |
Why?
|
Gastrin-Releasing Peptide | 1 | 2013 | 36 | 0.030 |
Why?
|
Receptors, Bombesin | 1 | 2013 | 27 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2024 | 81762 | 0.030 |
Why?
|
Young Adult | 1 | 2019 | 60066 | 0.030 |
Why?
|
Pyrimidines | 1 | 2005 | 3048 | 0.030 |
Why?
|
Histones | 1 | 2023 | 2601 | 0.030 |
Why?
|
Leadership | 1 | 2021 | 1397 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2023 | 2982 | 0.020 |
Why?
|
TRPV Cation Channels | 1 | 2013 | 244 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2004 | 4528 | 0.020 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 1105 | 0.020 |
Why?
|
Tumor Burden | 1 | 2017 | 1906 | 0.020 |
Why?
|
Genotype | 2 | 2018 | 13045 | 0.020 |
Why?
|
Epitopes | 1 | 2017 | 2528 | 0.020 |
Why?
|
Autoimmunity | 1 | 2019 | 1361 | 0.020 |
Why?
|
Adult | 3 | 2024 | 223646 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2005 | 5341 | 0.020 |
Why?
|
Nociceptors | 1 | 2013 | 460 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2020 | 2337 | 0.020 |
Why?
|
Transcription Factors | 1 | 2009 | 12168 | 0.020 |
Why?
|
Receptor, Notch2 | 1 | 2010 | 90 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2020 | 5797 | 0.020 |
Why?
|
Receptors, Cytokine | 1 | 2010 | 258 | 0.020 |
Why?
|
Risk Factors | 4 | 2020 | 74944 | 0.020 |
Why?
|
Cohort Studies | 2 | 2023 | 41754 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2009 | 381 | 0.020 |
Why?
|
Genome-Wide Association Study | 2 | 2018 | 12795 | 0.020 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2010 | 631 | 0.020 |
Why?
|
Somatomedins | 1 | 2007 | 179 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9374 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2020 | 3620 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 2013 | 1506 | 0.020 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2257 | 0.020 |
Why?
|
Immunoglobulins | 1 | 2010 | 855 | 0.020 |
Why?
|
Cell Compartmentation | 1 | 2007 | 383 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2013 | 1494 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2017 | 4249 | 0.020 |
Why?
|
Time Factors | 1 | 2008 | 40218 | 0.020 |
Why?
|
Graft vs Host Disease | 1 | 2019 | 3049 | 0.020 |
Why?
|
DNA Methylation | 1 | 2020 | 4428 | 0.020 |
Why?
|
Pregnancy | 1 | 2008 | 30256 | 0.020 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2013 | 1247 | 0.020 |
Why?
|
Spinal Cord | 1 | 2013 | 1811 | 0.020 |
Why?
|
Quality Improvement | 1 | 2020 | 3857 | 0.010 |
Why?
|
Animals, Genetically Modified | 1 | 2009 | 1563 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8647 | 0.010 |
Why?
|
Colony-Forming Units Assay | 1 | 2004 | 351 | 0.010 |
Why?
|
Melanocytes | 1 | 2007 | 509 | 0.010 |
Why?
|
Tandem Repeat Sequences | 1 | 2004 | 183 | 0.010 |
Why?
|
Mice, Nude | 1 | 2010 | 3623 | 0.010 |
Why?
|
Karyotyping | 1 | 2005 | 1177 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4580 | 0.010 |
Why?
|
Mitosis | 1 | 2007 | 1178 | 0.010 |
Why?
|
Alleles | 1 | 2013 | 6894 | 0.010 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2007 | 1151 | 0.010 |
Why?
|
Clone Cells | 1 | 2005 | 1670 | 0.010 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2005 | 658 | 0.010 |
Why?
|
Mutagenesis | 1 | 2005 | 1228 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16726 | 0.010 |
Why?
|
Gene Expression | 1 | 2013 | 7598 | 0.010 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2004 | 494 | 0.010 |
Why?
|
Benzamides | 1 | 2005 | 1379 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2009 | 6514 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 3772 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2005 | 1854 | 0.010 |
Why?
|
Quinazolines | 1 | 2004 | 1373 | 0.010 |
Why?
|
Cell Division | 1 | 2005 | 4473 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 65371 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2004 | 2414 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2005 | 4120 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2004 | 2709 | 0.010 |
Why?
|
Cell Cycle | 1 | 2004 | 2932 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2005 | 2433 | 0.010 |
Why?
|
Survival Rate | 1 | 2010 | 12840 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2004 | 4833 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2009 | 7608 | 0.010 |
Why?
|
Phosphorylation | 1 | 2005 | 8317 | 0.010 |
Why?
|
Models, Biological | 1 | 2010 | 9495 | 0.010 |
Why?
|
Graft Survival | 1 | 2004 | 3887 | 0.010 |
Why?
|
Rats | 1 | 2009 | 23760 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2005 | 12077 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14729 | 0.010 |
Why?
|
United States | 1 | 2017 | 73039 | 0.000 |
Why?
|